Skip to main content
Ionis Pharmaceuticals, Inc. (IONS)
NASDAQ: IONS · Real-Time Price · USD
43.10
+1.69 (4.08%)
At close: Aug 13, 2025, 4:00 PM
42.29
-0.81 (-1.88%)
After-hours: Aug 13, 2025, 7:49 PM EDT

Ionis Pharmaceuticals Revenue by Segment
Period Ending Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Mar 31, 2021Dec 31, 2020
Research and Development
603.82M 407.74M 412.20M 517.20M 519.24M 476.54M 479.40M 305.40M
Research and Development Growth
16.29% -14.44% -14.02% 69.35% 56.10% 71.59% 68.45% -46.00%
Commercial
340.66M 309.94M 293.36M 286.36M 294.71M 300.57M 308.75M 309.75M
Commercial Growth
15.59% 3.12% -4.98% -7.55% -1.13% 0.74% 1.94% -0.04%

Revenue by Product
Period Ending Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Mar 31, 2021Dec 31, 2020
Spinraza
223.56M 225.96M 216.41M 214.41M 224.45M 228.72M 240.51M 245.51M
Spinraza Growth
-0.40% -1.21% -10.02% -12.67% -6.44% -4.11% -0.65% 0.58%
Tegsedi and Waylivra
36.17M 30.83M 33.74M 34.74M 34.11M 36.57M 34.42M 32.42M
Tegsedi and Waylivra Growth
6.05% -15.69% -1.96% 7.17% 13.49% 22.78% 16.81% 3.03%
Wainua
35.16M 28.52M 20.28M - - - - - - - - - - - - - - - -
Source: Business metrics provided by Main Street Data and sourced from official company press releases and documents.